Materia Licenses Metathesis Catalyst Platform to Merck & Co., Inc.
December 14, 2006
Materia, Inc., a catalyst technology company, announced today the non-exclusive licensing of its metathesis platform to Merck & Co, Inc., a global pharmaceutical company...
Materia Announces NIH Funding
October 23, 2006
Materia has announced NIH funding for the further development of a metathesis-enabled reagent system for drug discovery.
Materia Announces Recent Product Development Success in Its Lanxess Partnership
August 16, 2006
Materia announced today recent product development success in its partnership with Lanxess Deutschland GmbH (formerly Bayer Material Science AG) in the field of nitrile rubbers.